15 Sep 2020

New data for Roche’s Ocrevus strengthens its position in MS

Roche has announced positive new data from the Phase IIIb CASTING trial of Ocrevus (ocrelizumab) in patients with relapsing-remitting multiple sclerosis (RRMS). Ocrevus is a recombinant monoclonal antibody (mAb) that…